Streptococcus salivarius M18 is a specific strain of Streptococcus salivarius originating from the human oral microbiome. The strain is deposited with the American Type Culture Collection as ATCC BAA-2593 and is also associated with the designation BLIS M18™.
The strain is a Gram-positive, catalase-negative, non-motile coccus that occurs in pairs or chains. Regulatory documentation describes M18 as a freeze-dried culture that can be supplied in a protective food-grade matrix.
The Australian TGA compositional guideline specifies NLT 1 × 10¹¹ CFU/g for the freeze-dried M18 ingredient. The FDA GRAS documentation also specifies a minimum viable count and provides food-use information for the strain.
MEDIOCON INC supports sourcing and supply of specialty probiotic strains according to customer requirements, viable count, formulation, grade and quality documentation.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Streptococcus salivarius M18 ATCC BAA 2593 Manufacturer & Supplier in India | MEDIOCON INC and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Streptococcus salivarius M18 ATCC BAA 2593 Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance